MedTrace Logo

Therapeutic Efficacy of "Abroma Agusta" in HbA1c % in NIDDM

NCT02065674 · Status: AVAILABLE · Type: EXPANDED_ACCESS

Last updated 2015-06-09

No results posted yet for this study

Summary

Objective: To ascertain whether homoeopathic medicine ABROMA AUGUSTA has a clinical role in changing the Glycated Hb Level in Diabetes mellitus Type II.

Abstract:

Background: Type 2 diabetes mellitus (T2DM) is one of the most important epidemic diseases in the world in this century, and accounts for 90% of cases of diabetes globally. Studies have suggested that Abroma Augusta plays a role in acute controlling blood glucose level. The aim of this study was to evaluate the efficacy of "Abroma Augusta Ѳ" in chronic control through GlycatedHb (HbA1c %) in Diabetes Mellitus Type 2 (NIDDM) as a pretest post-test study.

Conditions

  • Type II Diabetes Mellitus

Interventions

DRUG

Abroma Augusta Q (mother tincture)

30 drops in 1 cup of water three times a day for 3 months

Sponsors & Collaborators

  • Fr Muller Homoeopathic Medical College

    lead OTHER

Principal Investigators

  • dr rita chakraborty, MD · Fr Muller Homoeopathic Medical College

Eligibility

Min Age
30 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02065674 on ClinicalTrials.gov